An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months

NCT00806546 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
514
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

NuPathe Inc.